Poster presented at the American Society of Addiction Medicine (ASAM) annual meeting, May 2006.
Lawrence S. Brown Jr., MD, MPH (Addiction Research and Treatment Corporation, NY Node), Steven Allan Kritz, MD (Addiction Research and Treatment Corporation, NY Node), John Rotrosen, MD (VA New York Harbor Healthcare System, NYU School of Medicine, NY Node), R. Jeffrey Goldsmith, MD (Cincinnati VA Medical Center, OV Node), Edmund J. Bini, MD, MPH (VA New York Harbor Healthcare System, NYU School of Medicine, NY Node), James A. Robinson, MEd (Nathan Kline Institute).
In the US, users of illicit drugs will largely sustain the epidemics of HIV/AIDS, hepatitis C (HCV), and sexually transmitted infections (STI). Substance abuse treatment programs can play a major role in stemming these epidemics. Protocol CTN-0012 is a nationwide study, sponsored by the National Drug Abuse Treatment Clinical Trials Network (NIDA CTN), that examines these three infection groups from the perspective of administrators and clinicians working in substance abuse treatment programs, and the states within which they are located. The NIDA CTN has over 100 Community Treatment Programs (CTPs) with over 300 discreet substance abuse treatment sites in 17 nodes across the US. Three surveys were developed; one each for substance abuse treatment program administrators and clinicians, and one for state health and substance abuse department administrators. This report examines HIV/AIDS, HCV, and STI-related services provided by substance abuse treatment programs in the NIDA CTN from the perspective of the clinicians, medical and non-medical, expert and non-expert, working in these programs. The clinician survey looked at practices, program guidelines, knowledge, barriers, and opinions of clinicians caring for substance abusers within their program. Completed surveys were obtained from 1719 of 2207 targeted clinicians working at 265 substance abuse treatment sites. The breakdown of completed surveys was: (1) medical expert: 251; (2) medical non-expert: 115; (3) non-medical expert: 522; and (4) non-medical non-expert: 831. The extensive data obtained from this group of clinicians will be presented to inform public policy to encourage "best practices" in treating these epidemic infections.
(Poster, PowerPoint slides, English, 2006)
Keywords: Community health services | Health services research | Hepatitis C | HIV/AIDS | Research design | Sexually transmitted diseases | American Society of Addiction Medicine (ASAM) annual meeting, 2006
Document No: 128
Submitted by Lawrence S. Brown Jr., MD, MPH, FASAM, Lead Investigator (6/19/2005).